Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Chronic Renal Failure

  Free Subscription


Articles published in Curr Opin Nephrol Hypertens

Retrieve available abstracts of 77 articles:
HTML format



Single Articles


    July 2020
  1. COURBON G, Martinez-Calle M, David V
    Simultaneous management of disordered phosphate and iron homeostasis to correct fibroblast growth factor 23 and associated outcomes in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2020;29:359-366.
    PubMed     Abstract available


  2. EGSTRAND S, Olgaard K, Lewin E
    Circadian rhythms of mineral metabolism in chronic kidney disease-mineral bone disorder.
    Curr Opin Nephrol Hypertens. 2020;29:367-377.
    PubMed     Abstract available


  3. KURATA Y, Tanaka T, Nangaku M
    Hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of anemia in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2020;29:414-422.
    PubMed     Abstract available


    May 2020
  4. LIN F
    Molecular regulation and function of FoxO3 in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2020 May 13. doi: 10.1097/MNH.0000000000000616.
    PubMed     Abstract available


  5. NAIR S, Trivedi M
    Anemia management in dialysis patients: a PIVOT and a new path?
    Curr Opin Nephrol Hypertens. 2020;29:351-355.
    PubMed     Abstract available


    March 2020
  6. CAO J, Singh K
    Integrating risk prediction models into chronic kidney disease care.
    Curr Opin Nephrol Hypertens. 2020 Mar 19. doi: 10.1097/MNH.0000000000000603.
    PubMed     Abstract available


  7. GUERROT D, Humalda JK
    Blood pressure targets in chronic kidney disease: an update on the evidence.
    Curr Opin Nephrol Hypertens. 2020 Mar 9. doi: 10.1097/MNH.0000000000000601.
    PubMed     Abstract available


  8. CURTIS S, Komenda P
    Screening for chronic kidney disease: moving toward more sustainable health care.
    Curr Opin Nephrol Hypertens. 2020 Mar 5. doi: 10.1097/MNH.0000000000000597.
    PubMed     Abstract available


  9. BROGAN M, Astor BC, Melamed ML
    Vitamin D in chronic kidney disease: is there a role outside of PTH control?
    Curr Opin Nephrol Hypertens. 2020;29:243-247.
    PubMed     Abstract available


    February 2020
  10. IMAN Y, Harasemiw O, Tangri N
    Assessing physical function in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2020 Feb 25. doi: 10.1097/MNH.0000000000000594.
    PubMed     Abstract available


    January 2020
  11. BROGAN M, Astor BC, Melamed ML
    Vitamin D in chronic kidney disease: is there a role outside of PTH control?
    Curr Opin Nephrol Hypertens. 2020 Jan 31. doi: 10.1097/MNH.0000000000000591.
    PubMed     Abstract available


  12. URIBARRI J
    Chronic kidney disease and kidney stones.
    Curr Opin Nephrol Hypertens. 2020 Jan 16. doi: 10.1097/MNH.0000000000000582.
    PubMed     Abstract available


    December 2019
  13. KASSEM H, Chatila K
    Mineralocorticoid receptor antagonists in heart failure patients with chronic kidney disease: why, when, and how?
    Curr Opin Nephrol Hypertens. 2019 Dec 12. doi: 10.1097/MNH.0000000000000583.
    PubMed     Abstract available


    November 2019
  14. TANTISATTAMO E, Hanna RM, Reddy UG, Ichii H, et al
    Novel options for failing allograft in kidney transplanted patients to avoid or defer dialysis therapy.
    Curr Opin Nephrol Hypertens. 2019 Nov 16. doi: 10.1097/MNH.0000000000000572.
    PubMed     Abstract available


  15. RHEE CM, Nguyen DV, Nyamathi A, Kalantar-Zadeh K, et al
    Conservative vs. preservative management of chronic kidney disease: similarities and distinctions.
    Curr Opin Nephrol Hypertens. 2019 Nov 16. doi: 10.1097/MNH.0000000000000573.
    PubMed     Abstract available


  16. PURI I, Shirazi NM, Yap E, Saggi SJ, et al
    Intestinal dialysis for conservative management of Uremia.
    Curr Opin Nephrol Hypertens. 2019 Nov 12. doi: 10.1097/MNH.0000000000000571.
    PubMed     Abstract available


  17. JOSHI S, Hashmi S, Shah S, Kalantar-Zadeh K, et al
    Plant-based diets for prevention and management of chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2019 Nov 12. doi: 10.1097/MNH.0000000000000574.
    PubMed     Abstract available


  18. TANTISATTAMO E, Kalantar-Zadeh K
    Novel therapeutic approaches in chronic kidney disease and uremia management.
    Curr Opin Nephrol Hypertens. 2019 Nov 12. doi: 10.1097/MNH.0000000000000575.
    PubMed    


  19. CUPISTI A, Piccoli GB, Gallieni M
    Charcoal for the management of pruritus and uremic toxins in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2019 Nov 12. doi: 10.1097/MNH.0000000000000567.
    PubMed     Abstract available


  20. HAARHAUS M, Gilham D, Kulikowski E, Magnusson P, et al
    Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2019 Nov 11. doi: 10.1097/MNH.0000000000000570.
    PubMed     Abstract available


  21. PALMER BF, Clegg DJ
    Fluid overload as a therapeutic target for the preservative management of chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2019 Nov 9. doi: 10.1097/MNH.0000000000000563.
    PubMed     Abstract available


  22. CLEGG DJ, Palmer BF
    Potassium binding for conservative and preservative management of chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2019 Nov 9. doi: 10.1097/MNH.0000000000000564.
    PubMed     Abstract available


  23. MISKULIN DC
    Influenza in dialysis patients: an opportunity to decrease mortality?
    Curr Opin Nephrol Hypertens. 2019;28:607-614.
    PubMed     Abstract available


  24. MCMAHON GM, Singh AK
    Prolyl-hydroxylase inhibitors for the treatment of anemia in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2019;28:600-606.
    PubMed     Abstract available


  25. KODALI L, Turner A
    When are you too old to get a kidney transplants?
    Curr Opin Nephrol Hypertens. 2019;28:593-599.
    PubMed     Abstract available


    September 2019
  26. ALI I, Kalra P
    Risk prediction in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2019 Sep 9. doi: 10.1097/MNH.0000000000000553.
    PubMed     Abstract available


  27. RHEE CM
    Thyroid disease in end-stage renal disease.
    Curr Opin Nephrol Hypertens. 2019 Sep 2. doi: 10.1097/MNH.0000000000000542.
    PubMed     Abstract available


    August 2019
  28. TUNBRIDGE M, Cho Y, Johnson DW
    Urgent-start peritoneal dialysis: is it ready for prime time?
    Curr Opin Nephrol Hypertens. 2019 Aug 20. doi: 10.1097/MNH.0000000000000545.
    PubMed     Abstract available


  29. WELLES CC, Cervantes L
    Hemodialysis care for undocumented immigrants with end-stage renal disease in the United States.
    Curr Opin Nephrol Hypertens. 2019 Aug 8. doi: 10.1097/MNH.0000000000000543.
    PubMed     Abstract available


    July 2019
  30. PICKUP L, Radhakrishnan A, Townend JN, Ferro CJ, et al
    Arterial stiffness in chronic kidney disease: a modifiable cardiovascular risk factor?
    Curr Opin Nephrol Hypertens. 2019 Jul 29. doi: 10.1097/MNH.0000000000000535.
    PubMed     Abstract available


    June 2019
  31. CHEN W, Abramowitz MK
    Advances in management of chronic metabolic acidosis in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2019 Jun 19. doi: 10.1097/MNH.0000000000000524.
    PubMed     Abstract available


    May 2019
  32. MARTIN A
    Bone and heart health in chronic kidney disease: role of dentin matrix protein 1.
    Curr Opin Nephrol Hypertens. 2019 May 16. doi: 10.1097/MNH.0000000000000512.
    PubMed     Abstract available


  33. HSU S, Bansal N
    Updates in the management of heart failure for the chronic kidney disease patient.
    Curr Opin Nephrol Hypertens. 2019;28:262-266.
    PubMed     Abstract available


  34. RAMPERSAD C, Dart A
    Widening the lens to childhood: relevance and lifetime risk of kidney failure.
    Curr Opin Nephrol Hypertens. 2019;28:233-237.
    PubMed     Abstract available


    April 2019
  35. VOELKL J, Cejka D, Alesutan I
    An overview of the mechanisms in vascular calcification during chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2019 Apr 9. doi: 10.1097/MNH.0000000000000507.
    PubMed     Abstract available


    March 2019
  36. ZUK A, Bonventre JV
    Recent advances in acute kidney injury and its consequences and impact on chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2019 Mar 28. doi: 10.1097/MNH.0000000000000504.
    PubMed     Abstract available


    February 2019
  37. HA JT, Badve SV, Jun M
    Recent evidence for direct oral anticoagulants in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2019 Feb 14. doi: 10.1097/MNH.0000000000000493.
    PubMed     Abstract available


    January 2019
  38. GORAYA N, Wesson DE
    Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2019 Jan 23. doi: 10.1097/MNH.0000000000000491.
    PubMed     Abstract available


  39. WALD R, Thorpe KE, Walsh MW
    Leveraging pragmatic clinical trial design to advance phosphate management in end-stage renal disease.
    Curr Opin Nephrol Hypertens. 2019;28:34-39.
    PubMed     Abstract available


    December 2018
  40. ARMSTRONG ME, Thomas CP
    Diagnosis of monogenic chronic kidney diseases.
    Curr Opin Nephrol Hypertens. 2018 Dec 28. doi: 10.1097/MNH.0000000000000486.
    PubMed     Abstract available


  41. GOLDFARB DS
    Controversies in kidney stones and other chronic kidney disease topics.
    Curr Opin Nephrol Hypertens. 2018 Dec 24. doi: 10.1097/MNH.0000000000000485.
    PubMed    


  42. SHAH R, Sparks MA
    Renin-angiotensin system inhibition in advanced chronic kidney disease: how low can the kidney function go?
    Curr Opin Nephrol Hypertens. 2018 Dec 24. doi: 10.1097/MNH.0000000000000484.
    PubMed     Abstract available


  43. SRIPERUMBUDURI S, Hiremath S
    The case for cautious consumption: NSAIDs in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Dec 5. doi: 10.1097/MNH.0000000000000473.
    PubMed     Abstract available


    November 2018
  44. NG JK, Li PK
    Fluid management and bioimpedance study in peritoneal dialysis.
    Curr Opin Nephrol Hypertens. 2018 Nov 16. doi: 10.1097/MNH.0000000000000466.
    PubMed     Abstract available


  45. FRIEDMAN DJ
    Genes and environment in chronic kidney disease hotspots.
    Curr Opin Nephrol Hypertens. 2018 Nov 16. doi: 10.1097/MNH.0000000000000470.
    PubMed     Abstract available


  46. BURTON JO, Graham-Brown MPM
    Nocturnal hemodialysis: an underutilized modality?
    Curr Opin Nephrol Hypertens. 2018;27:472-477.
    PubMed     Abstract available


  47. PASUPULATI AK, Menon RK
    Growth hormone and chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Nov 1. doi: 10.1097/MNH.0000000000000468.
    PubMed     Abstract available


    October 2018
  48. VALDIVIELSO JM, Jacobs-Cacha C, Soler MJ
    Sex hormones and their influence on chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Oct 12. doi: 10.1097/MNH.0000000000000463.
    PubMed     Abstract available


  49. HANSSEN NMJ, Stehouwer CDA, Schalkwijk CG
    Methylglyoxal stress, the glyoxalase system, and diabetic chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Oct 12. doi: 10.1097/MNH.0000000000000465.
    PubMed     Abstract available


    September 2018
  50. BEAUBIEN-SOULIGNY W, Bouchard J, Denault A
    Point-of-care ultrasound in end-stage kidney disease: beyond lung ultrasound.
    Curr Opin Nephrol Hypertens. 2018 Sep 3. doi: 10.1097/MNH.0000000000000453.
    PubMed     Abstract available


  51. HASEGAWA S, Tanaka T, Nangaku M
    Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018;27:331-338.
    PubMed     Abstract available


    August 2018
  52. KALIM S
    Protein carbamylation in end stage renal disease: is there a mortality effect?
    Curr Opin Nephrol Hypertens. 2018 Aug 24. doi: 10.1097/MNH.0000000000000454.
    PubMed     Abstract available


  53. NIANG A, Iyengar A, Luyckx VA
    Hemodialysis versus peritoneal dialysis in resource-limited settings.
    Curr Opin Nephrol Hypertens. 2018 Aug 24. doi: 10.1097/MNH.0000000000000455.
    PubMed     Abstract available


  54. PONCE D, Brabo AM, Balbi AL
    Urgent start peritoneal dialysis.
    Curr Opin Nephrol Hypertens. 2018 Aug 22. doi: 10.1097/MNH.0000000000000451.
    PubMed     Abstract available


    July 2018
  55. TABINOR M, Davies SJ
    The use of bioimpedance spectroscopy to guide fluid management in patients receiving dialysis.
    Curr Opin Nephrol Hypertens. 2018 Jul 30. doi: 10.1097/MNH.0000000000000445.
    PubMed     Abstract available


  56. KALRA PA, Burlacu A, Ferro CJ, Covic A, et al
    Which anticoagulants should be used for stroke prevention in non-valvular atrial fibrillation and severe chronic kidney disease?
    Curr Opin Nephrol Hypertens. 2018 Jul 16. doi: 10.1097/MNH.0000000000000443.
    PubMed     Abstract available


  57. ERBEN RG
    alpha-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent.
    Curr Opin Nephrol Hypertens. 2018;27:229-235.
    PubMed     Abstract available


    June 2018
  58. ALI S, Dave N, Navaneethan SD
    Emerging therapeutic options for management of anaemia in with patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Jun 22. doi: 10.1097/MNH.0000000000000434.
    PubMed    


  59. MACDOUGALL IC
    Iron therapy for managing anaemia in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Jun 13. doi: 10.1097/MNH.0000000000000436.
    PubMed     Abstract available


    May 2018
  60. JELKMANN W
    Activin receptor ligand traps in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 May 29. doi: 10.1097/MNH.0000000000000433.
    PubMed     Abstract available


  61. DUBIN RF
    Application of echocardiographic data in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 May 16. doi: 10.1097/MNH.0000000000000419.
    PubMed     Abstract available


  62. GUPTA N, Wish JB
    Erythropoietin mimetic peptides and erythropoietin fusion proteins for treating anemia of chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 May 4. doi: 10.1097/MNH.0000000000000430.
    PubMed     Abstract available


  63. DEKKER MJE, Kooman JP
    Fluid status assessment in hemodialysis patients and the association with outcome: review of recent literature.
    Curr Opin Nephrol Hypertens. 2018;27:188-193.
    PubMed     Abstract available


    April 2018
  64. STRAUSSER SA, Nakano D, Souma T
    Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response.
    Curr Opin Nephrol Hypertens. 2018 Apr 26. doi: 10.1097/MNH.0000000000000424.
    PubMed     Abstract available


  65. MOE SM
    Rationale to reduce calcium intake in adult patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Apr 26. doi: 10.1097/MNH.0000000000000416.
    PubMed     Abstract available


  66. SCIALLA JJ
    Evidence basis for integrated management of mineral metabolism in patients with end-stage renal disease.
    Curr Opin Nephrol Hypertens. 2018 Apr 6. doi: 10.1097/MNH.0000000000000417.
    PubMed     Abstract available


    March 2018
  67. STELLER WAGNER MARTINS C, Jorgetti V, Moyses RMA
    Time to rethink the use of bone biopsy to prevent fractures in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Mar 31. doi: 10.1097/MNH.0000000000000418.
    PubMed     Abstract available


  68. ASHLEY J, Sood MM
    Novel oral anticoagulants in chronic kidney disease: ready for prime time?
    Curr Opin Nephrol Hypertens. 2018 Mar 22. doi: 10.1097/MNH.0000000000000410.
    PubMed     Abstract available


  69. CONNELLY K, Collister D, Tangri N
    Fracture risk and treatment in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Mar 15. doi: 10.1097/MNH.0000000000000411.
    PubMed     Abstract available


    February 2018
  70. LI T, Xie Y, Al-Aly Z
    The association of proton pump inhibitors and chronic kidney disease: cause or confounding?
    Curr Opin Nephrol Hypertens. 2018 Feb 9. doi: 10.1097/MNH.0000000000000406.
    PubMed     Abstract available


    January 2018
  71. HAAS M
    Evolving criteria for the diagnosis of antibody-mediated rejection in renal allografts.
    Curr Opin Nephrol Hypertens. 2018 Jan 2. doi: 10.1097/MNH.0000000000000398.
    PubMed     Abstract available


    December 2017
  72. RAO M, Jaber BL, Balakrishnan VS
    Chronic kidney disease and acquired mitochondrial myopathy.
    Curr Opin Nephrol Hypertens. 2017 Dec 20. doi: 10.1097/MNH.0000000000000393.
    PubMed     Abstract available


    November 2017
  73. KRAUT JA, Madias NE
    Retarding progression of chronic kidney disease: use of modalities that counter acid retention.
    Curr Opin Nephrol Hypertens. 2017 Nov 14. doi: 10.1097/MNH.0000000000000386.
    PubMed     Abstract available


  74. SCHMIDT RJ
    Incorporating supportive care into the hemodialysis unit.
    Curr Opin Nephrol Hypertens. 2017;26:530-536.
    PubMed     Abstract available


    October 2017
  75. WALTHER CP, Chandra A, Navaneethan SD
    Blood pressure parameters and morbid and mortal outcomes in nondialysis-dependent chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2017 Oct 16. doi: 10.1097/MNH.0000000000000375.
    PubMed     Abstract available


    September 2017
  76. GOLPER TA
    Incremental dialysis: review of recent literature.
    Curr Opin Nephrol Hypertens. 2017 Sep 11. doi: 10.1097/MNH.0000000000000362.
    PubMed     Abstract available


  77. SY J, Johansen KL
    The impact of frailty on outcomes in dialysis.
    Curr Opin Nephrol Hypertens. 2017 Sep 9. doi: 10.1097/MNH.0000000000000364.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: